CRESCENT BIOPHARMA INC.

$CBIO
← All companies Sign in to track
Institutional coverage

53 13F filers hold $CBIO.

13F holders
53
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

3 holders · Q1 2026

$CBIO is held by 3 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.77%, with an average of 0.28% of portfolio. Largest holder: Vestal Point Capital, LP at 0.77%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

01
Vestal Point Capital, LP
0.77% held
α +16.2pts
02
ADAR1 Capital Management, LLC
0.05% held
α +74.0pts
03
Citigroup Inc.
0.00% held
α +26.3pts

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 53 · Source: 13F-HR
01
Fir Tree Capital Management LP
0.84% of portfolio
2,748,763 sh
02
TB Capital Gestao de Recursos Ltda.
—
2,597,744 sh
03
Bienville Capital Management, LLC
1.46% of portfolio
2,133,576 sh
04
True Blue (BVI) Ltd
4.27% of portfolio
1,677,852 sh
05
Siemens Pension Trust E V
0.04% of portfolio
1,510,033 sh
06
Main Street Group, LTD
0.77% of portfolio
1,500,000 sh
07
Fairmount Funds Management LLC
1.48% of portfolio
1,387,866 sh
08
VR Adviser, LLC
1.04% of portfolio
1,387,864 sh
09
Municipal Employees' Retirement System of Michigan
3.18% of portfolio
1,312,615 sh
10
Mason Capital Management LLC
1.08% of portfolio
1,160,000 sh
See all 53 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $CBIO in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CBIO in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:39 UTC.